Very early researchUnknownNCT04045847What this trial is testingCD147-CART Cells in Patients With Recurrent Malignant Glioma.Who this might be right forRecurrent GlioblastomaCD147 Positive Xijing Hospital 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT04257578What this trial is testingAcalabrutinib and Anti-CD19 CAR T-cell Therapy for the Treatment of B-cell LymphomaWho this might be right forB-Cell Non-Hodgkin LymphomaDiffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedHigh Grade B-Cell Lymphoma+5 more University of Washington 23
Very early researchUnknownNCT03407859What this trial is testingSequential Treatment With CD20/CD22/CD10-CART After CD19-CART Treatment Base on MRD in Relapsed/Refractory B-ALLWho this might be right forTherapy Related Leukemia Zhujiang Hospital 100
Testing effectiveness (Phase 2)Study completedNCT03232619What this trial is testingCD19-CART Treatment for ALLWho this might be right forAcute Leukemia Bioray Laboratories 4
Testing effectiveness (Phase 2)Looking for participantsNCT06066346What this trial is testingTalquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell TherapyWho this might be right forMultiple Myeloma Memorial Sloan Kettering Cancer Center 17
Early research (Phase 1)WithdrawnNCT04556266What this trial is testingA Phase I Trial of Donor- Derived 19-28z CAR T Cells Following Allogeneic Transplant for the Treatment of CD19 MalignanciesWho this might be right forLeukemiaLymphomaLymphoma, B-Cell Memorial Sloan Kettering Cancer Center
Early research (Phase 1)UnknownNCT03767725What this trial is testingAnti-BCMA or/and Anti-CD19 CART Cells Treatment of Relapsed Multiple MyelomaWho this might be right forMultiple Myeloma in Relapse Shenzhen Second People's Hospital 10
Early research (Phase 1)Not Yet RecruitingNCT07101549What this trial is testingTreating Nectin-4-positive Advanced Solid Tumors With R-Star001 (Nectin-4-CART-IL18)Who this might be right forAdvanced Solid Tumors changjianhua 25
Very early researchUnknownNCT04626726What this trial is testingAdult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell TransplantationWho this might be right forAdult B Acute Lymphoblastic Leukemia Hebei Senlang Biotechnology Inc., Ltd. 50
Testing effectiveness (Phase 2)UnknownNCT03633773What this trial is testingSafety and Efficacy Evaluation of MUC-1 CART in the Treatment of Intrahepatic CholangiocarcinomaWho this might be right forIntrahepatic Cholangiocarcinoma Second Affiliated Hospital, Zhejiang University, School of Medicine 9
Early research (Phase 1)UnknownNCT03563326What this trial is testingIntraperitoneal Infusion of EpCAM CAR-T Cell in Advanced Gastric Cancer With Peritoneal Metastasis (WCH-GC-CART)Who this might be right forNeoplasm, StomachMetastases, NeoplasmNeoplasm Seeding Jian-Kun Hu 40
Not applicableUnknownNCT04237428What this trial is testingCD19-CART in the Treatment of R/R CD19 Positive Non-Hodgkin's LymphomaWho this might be right forNon Hodgkin Lymphoma PersonGen BioTherapeutics (Suzhou) Co., Ltd. 20
Early research (Phase 1)Study completedNCT02028403What this trial is testingSafety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral TherapyWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 8
Testing effectiveness (Phase 2)Study completedNCT00799136What this trial is testingA Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARLWho this might be right forLymphoma, AIDS RelatedHIV Infections Ontario Clinical Oncology Group (OCOG) 6
Testing effectiveness (Phase 2)Ended earlyNCT03743246What this trial is testingEvaluate the Safety and Efficacy of JCAR017 in Pediatric Subjects With Relapsed/Refractory (r/r) B-cell Acute Lymphoblastic Leukemia (B-ALL) and B-cell Non-Hodgkin Lymphoma (B-NHL)Who this might be right forPrecursor Cell Lymphoblastic Leukemia-LymphomaLymphoma, Non-Hodgkin Celgene 21
Testing effectiveness (Phase 2)Looking for participantsNCT06236139What this trial is testingCell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate CancerWho this might be right forMetastatic Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8 Fred Hutchinson Cancer Center 48
Early research (Phase 1)Looking for participantsNCT07698600What this trial is testingA Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIVWho this might be right forHIV -1 Infection BioNTech SE 126
Not applicableTemporarily pausedNCT06310811What this trial is testingAnti-CD19 CAR-T Cell Therapy in Participants With Moderate to Severe Active Systemic Lupus ErythematosusWho this might be right forSafetyEffective Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 12
Early research (Phase 1)WithdrawnNCT05950113What this trial is testingCART-BCMA/CS1 in Treating Patients With Relapsed or Refractory Multiple MyelomaWho this might be right forRecurrent Multiple MyelomaRefractory Multiple Myeloma Jonsson Comprehensive Cancer Center
Early research (Phase 1)Active Not RecruitingNCT05665062What this trial is testingAutologous CD19 CAR-T Cell Therapy (SYNCAR-001) + Orthogonal IL-2 (STK-009) in Subjects With CD19+ Hematologic MalignanciesWho this might be right forCLL/SLLNHLMantle Cell Lymphoma+4 more Synthekine 36